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Investigating the role of the p63 isoform ΔNp63 in 
lung stem cell populations and lung cancer 
Sarah Jiaxi Wu 
Supervisory Professor: Elsa R. Flores, Ph.D. and Min Gyu Lee, Ph.D. 
 
Abstract 
Cell of origin studies have determined separate populations of lung progenitor cells that 
give rise to lung adenocarcinoma and squamous cell carcinoma. ΔNp63 is known to 
regulate lung development but its role in lung cancer progression remains unclear. We 
utilized a ΔNp63-specific conditional knockout mouse model to determine ΔNp63’s role 
in lung progenitor cells and lung cancer. In vivo and in vitro experiments revealed a role 
for ΔNp63 in maintaining lung progenitor cells. ChIP-seq results indicate that deletion of 
ΔNp63 results in robust loss of enhancer histone marks at cell identity genes for lung 
progenitor populations of basal cells and AT2 cells. Analysis of ΔNp63-regulated 
pathways uncovered that ΔNp63 regulates cell-type-specific genes as well as common 
genes for basal cells and AT2 cells. Our experiments using a deactivated cas9 system 
showed that co-targeting of ΔNp63 and the enhancer activator p300 to p63 binding 
motifs significantly enhanced the transcription of ΔNp63-regulated genes, indicating that 
ΔNp63 directly regulates enhancer region activity. These novel findings suggest that 
ΔNp63 acts as a master regulator of transcriptional and epigenetic networks in lung 
progenitor cells whose oncogenic characteristics are essential to the initiation and 
progression of lung cancer. 
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Chapter 1: Introduction 
 
1.1 Lung Cancer Subtypes, Diagnosis and Treatment 
 
Lung cancer is the number one cause of cancer mortality worldwide, contributing 
to more deaths than breast, colon, and prostate cancer combined (Siegel et al., 
2019)(Siegel et al., 2019)(Siegel et al., 2019). Lung cancer can be divided into two major 
subtypes: small cell lung cancer and non-small cell lung cancer. Non-small-cell lung 
cancer (NSCLC) comprises 85% of all lung cancers with adenocarcinoma and 
squamous cell carcinoma (SCC) as the first and second most common subtypes, 
respectively. Currently, the mean survival of patients with metastatic NSCLC is around 1 
year, with a 3.5% 5-year survival rate (Cataldo et al., 2011).  
 
The high degree of lung cancer mortality can be attributed to a lack of effective 
diagnostic tools and targeted therapeutics (Herbst et al., 2008). A 2011 SEER cancer 
statistics review examining at lung cancer diagnosis and survival by stage found that 
while 5-year survival was at 52% for localized lesions, these comprised only 15% of all 
diagnoses (Howlader N, 2011). The vast majority of patients were diagnosed when they 
already had distal metastases (56%) with a 4% 5-year survival. Early diagnosis of lung 
cancer has been an area of focus, but current options are limited. Current diagnostic 
modalities for lung cancer include imaging such as computerized tomography (CT) or 
positron emission tomography (PET) scans (Wang et al., 2018). However, these 
methods have not been shown to be able to accurately detect small lesions and there is 
a high false positive rate. This may contribute to the high mortality rate of lung cancer, as 
there is no reliable method to detect early lesions, whereas breast, colon, and prostate 
cancer have established protocols for early detection. Development of new diagnostic 
 3 
mechanisms to determine pre-malignant lesions could be essential to address the high 
mortality rate of lung cancer. 
 
Because of the poor response to first-line cisplatin-based chemotherapy, 
therapies against molecular targets have been an area of intense focus. Current 
guidelines presented at ASCO 2018 suggest tyrosine kinase inhibitors as treatment for 
tumors with mutations in EGFR, ALK, ROS; cancers lacking mutations are treated with 
PD-1 inhibitor pembrolizumab in combination with traditional chemotherapeutic agents 
(Bironzo and Di Maio). The poor prognosis and lack of effective treatment of lung cancer 
identifies a need to better understand its molecular basis and development in order to 
develop new targeted therapies.  
 
1.2 Stem Cells as Cells of Origin of Cancer 
 
Adult stem cell populations play an important role in dividing into differentiated 
cell types as well as self-renewal to maintain the stem cell pool. Due to similarities in 
signaling pathways and self-renewal abilities between transformed cells and stem cells, 
it is hypothesized that cancer may originate from transformed stem cells (Reya et al., 
2001, Visvader, 2011). As differentiated cells rarely self-renew or divide, any mutations 
incurred in these cells are not maintained in the population. However, the adult stem 
cells are able to self-renew and create a population of cells maintain any oncogenic 
mutation, especially those with mutations that promote growth-signaling pathways. 
Subsequent mutations in this cell population leads to expansion of the population and 
eventual progression into a tumor. As the pathogenesis of lung cancer is often due to 
exposure to carcinogenic agents like smoking over a prolonged period of time, the 
transformed stem cell hypothesis is particularly relevant. 
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1.3 Lung Stem Cell Populations and Role as Cells of Origin for Cancer 
 
There are numerous stem cell populations of the lung, which are involved in 
regeneration of distinct regions (Eramo et al.). The lung can be separated into two main 
compartments with differing cellular makeup. The proximal lung is comprised of the 
trachea and bronchioles, which are responsible for transporting and conditioning air 
that’s breathed in. The main stem cell population of the proximal lung is the basal cell. 
The basal stem cells of the trachea differentiate into ciliated and goblet cells (Rock et al.) 
and are thought to be the cell of origin for lung SCC as both populations express similar 
histological markers p63 and keratin 5 (Krt5) (Hanna and Onaitis, 2013). Jeong et al. 
recently published that overexpression of KEAP1 and deletion of p53 in basal cells can 
result in development of lung SCC in mice (Jeong et al.). 
The distal lung is comprised of the alveolar structures that promote gas 
exchange. The two main epithelial cell populations are type I alveolar cells (AT1) and 
type II alveolar cells (AT2) (Sutherland and Berns). Kim et al. identified a population of 
bronchioalveolar stem cells (BASCs), which exhibited stem-like properties and were 
hypothesized to be the cell of origin for adenocarcinoma (Kim et al., 2005). Xu et al. 
demonstrated that while BASCs could progress to hyperplasia, only the type II alveolar 
cells, a multipotent cell responsible for maintaining cells in the alveoli, could form 
adenocarcinomas (Xu et al., 2012).  
 
1.4 p53 Family of Transcription Factors  
 
p53 is known as the guardian of the genome and is responsible for maintaining 
genomic integrity of the cell. Sequencing initiatives like the Cancer Genome Atlas 
(TCGA) have found p53 to be the most commonly mutated or deleted gene in the 
majority of cancers, demonstrating its importance in the pathogenesis of cancer. P53 is 
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a transcription factor that is able to form tetrameric complexes and promote transcription 
of key genes involved in DNA damage and apoptosis response. Efforts have been made 
to target p53 pharmacologically with limited success. Because of the frequent deletion 
and mutation of p53, an alternative strategy is to look to the other members of the family 
to target p53 signaling pathways.  
Other family members, p63 and p73, have been found to have similar structure to 
p53, but also with distinct functions. P63 specifically has been found to have two major 
isoforms, which arise from distinct promoters: TAp63 and ΔNp63. TAp63 has tumor 
suppressive functions (Su et al.) while ΔNp63 generally has oncogenic properties 
(Figure 1). The mechanisms of ΔNp63 tumorigenesis are diverse, including dominant 
negative antagonism of p53, regulation of miRNA biogenesis, and direct transcriptional 
targets (Chakravarti et al., 2014, Tran et al., 2013). Because of the difficult nature of 
distinguishing the isoforms, p63 isoforms have been lumped together and their individual 
functions have been difficult to discern. By use of specific isoform knockout mouse 
models, the distinct functions of TAp63 and ΔNp63 can be elucidated.  
Our laboratory has developed p63 isoform specific conditional knockout mouse 
models to study the individual functions of these isoforms, focusing on their roles in stem 
cell maintenance and in tumorigenesis. Our lab has shown that in the epidermis, TAp63 
and ΔNp63 regulate distinct stem cell populations; TAp63 maintains stem cells in the 
dermal papilla while ΔNp63 maintains epidermal basal cells (Su et al., 2009). We have 
demonstrated that ΔNp63 is critical for terminal differentiation of the epidermis 
(Chakravarti et al., 2014) and acts as an oncogene by inhibiting p53, TAp63, and TAp73 
function (Venkatanarayan et al., 2015). Importantly, we have also identified novel ways 
of therapeutically targeting cancers through manipulation of ∆Np63 (Napoli et al., 2016). 
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Figure 1: Structure of p63 gene in comparison to p53.  
The structure of the p63 gene has similarity to p53(Su et al., 2013). P63 has two 
promoters that result in transcription of unique isoforms. The promoter at exon one leads 
to transcription of the TAp63 isoform, which contains a transactivation domain (TA) as 
well as the DNA-binding domain (DBD) and oligomerization domain (OD). The ΔNp63 
isoform is transcribed from an alternative promoter at the 3’ exon and does not contain 
the transactivation domain. In addition to variability at the N-terminal, there exist splice 
variants at the C-terminal, some of which contain a sterile alpha motif (SAM) domain.  
 
 
Figure used with permission from Su X, Chakravarti D, Flores ER. p63 steps into the 
limelight: crucial roles in the suppression of tumorigenesis and metastasis. Nat Rev 
Cancer. 2013 Feb;13(2):136-43. License number: 4384531506832. 
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1.5 Role of p63 in Lung Stem Cells and Lung Cancer 
 
The transcription factor, p63, a member of the p53 family, is expressed in the 
basal stem cells of the lung (Wansleeben et al., 2013, Daniely et al., 2004) and is a 
master regulator of stem cell maintenance and differentiation of epithelial tissues (Su et 
al., 2013). The characterization of the role of p63 in the lung epithelium is complex, as 
there are two isoforms with distinct roles, TAp63 and ΔNp63. ΔNp63 was identified as 
significantly altered in 44% of primary lung squamous cell carcinomas by the Cancer 
Genome Atlas (TCGA) (Cancer Genome Atlas Research, 2012). Compared to p53, 
which is commonly mutated, p63 is often amplified in both lung squamous cell 
carcinoma and lung adenocarcinoma (Figure 2). Analysis of TCGA RNA-seq data using 
SpliceSeq (Ryan et al., 2012) shows ΔNp63 is the main p63 isoform expressed in lung 
squamous cell carcinoma and the classical molecular subtype has the highest ΔNp63 
expression (Figure 3). ΔNp63 has been identified as an oncogene in squamous cell 
carcinoma of the skin, which shares molecular characteristics and p63 expression 
patterns with lung SCC (Yan et al., 2011). Our lab’s analysis comparing the ΔNp63 gene 
signature generated from keratinocytes and lung SCC from TCGA also identify ΔNp63 
as a putative oncogene (Abbas et al., 2018). p63, specifically ΔNp63 or p40, has been 
utilized as a diagnostic marker for lung squamous cell carcinoma (Daniely et al., 2004). 
P63 staining is visible in the nuclei of basal cells of the tracheal epithelium. Squamous 
metaplasia and squamous cell carcinoma tissue also stains positive for p63 (Daniely et 
al., 2004). While ΔNp63 staining is considered specific and diagnostic for lung 
squamous cell carcinoma, a small percentage of lung adenocarcinomas also stain 
positive for ΔNp63. A study of 150 adenocarcinoma samples demonstrated positive 
staining in 27 tumors (18%) (Nonaka, 2012). The relative lack of mechanistic 
understanding of p63 isoforms in the lung necessitates further study. 
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Figure 2: p53 family alterations in TCGA lung squamous cell carcinoma and lung 
adenocarcinoma.  
A comparison of p53 family members TP53, TP63, and TP73 in lung squamous cell 
carcinoma and lung adenocarcinoma. While TP53 is more often mutated in lung cancer, 
TP63 is amplified in both lung squamous cell carcinoma and lung adenocarcinoma. 
Cbioportal data, TCGA (LUSC and LUAD, all samples). 
 
 
 
 
 
 
 
 
Lung Squamous Cell Carcinoma 
Lung Adenocarcinoma 
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Figure 3: p63 isoform levels in TCGA lung squamous cell carcinoma (LUSC) and 
lung adenocarcinoma (LUAD). 
Analysis of RNA sequencing data from the TCGA lung squamous cell carcinoma (LUSC) 
and lung adenocarcinoma (LUAD) datasets. While both LUSC and LUAD have 
statistically significantly higher levels of ΔNp63 mRNA compared to TAp63, levels of 
ΔNp63 mRNA are significantly higher in LUSC (average relative expression of 2000 vs 
100).  
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1.6 Epigenetics in Cell Identity and Development of Cancer 
While cancer biology has long focused on gene mutations as drivers of 
tumorigenesis, increasingly focus has turned to epigenetic regulation of gene expression 
as a key contributor to the etiology of cancer. Recent work has identified epigenetic 
mechanisms of gene regulation as key modulators of cancer progression. These 
processes can dynamically change gene regulation without changes to the DNA, 
allowing for fast adaptation. Enhancers have been identified as key spatiotemporal 
regulators of gene expression. Enhancer elements are distant from the promoter and 
have been shown to have the ability to loop around to interact with the promoter and 
recruit transcription factors, mediator proteins, and RNA polymerases. Enhancers are 
commonly marked by two histone modifications: acetylated H3K27 (H3k27ac) and 
monomethyl H3K4 (H3K4me1). Enhancers which cluster together in large regions of the 
genome over 10 kilobases are deemed super-enhancers and have been associated with 
genes that designate cell identity (Whyte et al., 2013). Interest has grown in 
understanding the regulation of super-enhancers as super-enhancer-associated genes 
are the most highly expressed in the cell and are thought to play a key role in the biology 
of the cancer (Sur and Taipale, 2016). Recent development of pharmacologic 
mechanisms to target super-enhancer biology has also increased interest in 
understanding more about how cancer cells epigenetically regulate gene expression. 
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2. Chapter 2: Materials and Methods 
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Chapter 2: Materials and Methods 
 
2.1 Mouse Genotypes 
The following mouse strains were generated: 
ΔNp63fl/fl; RosaM/M 
TAp63fl/fl; RosaM/M 
LSLKrasG12D/+; RosaM/M 
ΔNp63fl/fl; LSLKrasG12D/+; RosaM/M 
 
ΔNp63fl/fl and TAp63fl/fl mice were generated in the Flores lab (Su et al., 2010, 
Chakravarti et al., 2014). LSLKrasG12D/+ and RosaM/M mice were purchased from Jackson 
labs and National Institutes of Health.  
 
2.2 Mouse Husbandry 
Mice were aged until 6-8 weeks old before being utilized in experiments. Both male and 
female mice were used at equal ratios. Littermates were randomly assigned to 
experimental groups. Animals were maintained according to established protocols 
approved by the Institutional Animal Care and Use Committee of MD Anderson Cancer 
Center and Moffitt Cancer Center.  
 
2.3 Mouse Tissue Processing 
Lung tissue was isolated from a euthanized mouse and preserved in 10% formaldehyde 
for 24 hours, followed by preservation in 70% ethanol for 24 hours. Lung and trachea 
tissue were then processed and embedded into paraffin by the MD Anderson Research 
Histology Core Lab.  
 
2.4 Immunohistochemistry 
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Unstained slides were dewaxed and rehydrated by washing in sequential rinses of 
xylene, 100% ethanol, 90% ethanol, 70% ethanol, and PBS. Following this step is three 
washes of PBS/0.2% Triton-X-100 to enable permeabilization of tissues. Blocking was 
performed with PBS/10% normal donkey serum.  
 
2.5 Microscopy and Image Processing 
Bright field and immunofluorescence images were taken on an Olympus IX83 
microscope. Images were processed in Adobe Photoshop.  
 
2.6 Image Quantification 
Immunohistochemical and immunofluorescence images were quantified using ImageJ 
cell counting software. 
 
2.7 Intratracheal Infection of Mice 
6-8 week old mice were anesthetized with a ketamine/xylazine (ketamine 100 mg/kg IP, 
xylazine 10 mg/kg IP), intubated using a fiber optic illuminated catheter (DuPage et al., 
2009), and given 2.5x107 PFU viral dosage suspended in 100 microliters of minimal 
essential media (MEM). CMV-cre and CMV-empty adenovirus was obtained from the 
BCM viral core.  
 
2.8 Scoring of Tracheal Sections 
3 H&E sections of trachea cut 50 µms apart per mouse were analyzed using the 
Olympus Cellsense software. Tracheal epithelial height was measured from the 
basement membrane to the apex of the membrane. Epithelial separation was defined as 
length of epithelium where the basement membrane was separated.  
 
2.9 Lung Tumor Grading 
 14 
H&E sections of mouse lungs were examined and lung lesions were graded into atypical 
adenomatous hyperplasia (AAH), grade 1, and grade 2+ (Jackson et al., 2001). For each 
mouse, 3 H&E sections of 5 lung lobes taken 100 µms apart were analyzed.    
 
2.10 Polidocanol Administration 
50 µl of 2% polidocanol was administered to the mouse trachea by a catheter inserted 
into the trachea (Paul et al., 2014, DuPage et al., 2009).  
 
2.11 Cell Culture of Tumor Cell Lines 
The following human cell lines were utilized: H520, H2170, H358. Cells were cultured at 
37C in 5% CO2 conditions. RPMI media supplemented with 1% L-glutamine, 1% 
penicillin/streptomycin, and 10% FBS. Cell lines were authenticated by STR profiling 
(MD Anderson Cell Line Authentication Service).  
 
2.12 Mouse Tumor Xenografts 
5x106 human lung cancer cells were mixed in 1:1 ratio with growth factor reduced 
matrigel in a total volume of 200 microliters to inject per flank in nude mice. Male nude 
mice were utilized for xenograft studies. Mice were injected with control cell line in the 
left flank and experimental cell line in the right flank. Tumors were measured weekly with 
calipers until one side’s final volume reached around 2 cm3. Mice were euthanized and 
the tumors were excised, measured, fixed in 10% formaldehyde, and submitted for 
histological processing. 
 
2.13 Tumor Cell Line Soft Agar Colony Assay 
Human lung cancer cell lines were plated in 100 µl of 1:1 ratio of RPMI: growth factor 
reduced matrigel at 100 cells per well in a 96 well plate, with 100 µl of RPMI media 
plated on top of the matrigel layer. The top 100 µl of RPMI was changed every 2 days. 
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To analyze colony numbers, the matrigel was dissolved with cell recovery solution 
(Corning) at 4C for 1 hour and the plate was scanned using the Celigo colony analysis 
software.   
 
2.14 Isolation of Mouse Basal Stem Cells 
The tracheas from ΔNp63fl/fl; RosaM/M mice were isolated and digested with papain at 37 
degrees Celsius (Rock et al., 2009). Basal cells were cultured on mitomycin treated J2-
3T3 feeders for 7 days in MTEC media with rock inhibitor.  
 
2.15 Adenovirus Infection of Cells In Vitro 
Cells were infected at a multiplicity of infection (MOI) of 100. Adenovirus (adeno-empty 
and adeno-cre) was added to cells in a total volume of 2 ml and incubated at 37C for 1 
hour, agitating every 15 minutes. Cells were then washed with PBS.  
 
2.16 Basal Stem Cell Proliferation Assay 
Basal cells were plated on a bed of mitomycin treated J2-3T3 feeders. EdU was added 
to the media for 24 hours. Cells were fixed with paraformaldehyde and developed using 
the Click-it EdU Alexa Fluor 488 imaging kit (Invitrogen). Data was analyzed on the 
Nexcelom Celigo.  
 
2.17 Basal Stem Cell Sphere Formation Assay 
Basal cells in single cell suspension were seeded into 100 µl of 1:1 growth factor 
reduced matrigel:MTEC media in a 96 well plate. 100 µl of MTEC plus media was 
seeded on top of the matrigel. Media was changed every 2 days. Cells were grown for 1 
week. Matrigel was dissolved with cell recovery solution (Corning) and the plate was 
placed at 4C for 2 hours to allow the spheres to sink to the bottom of the plate. The plate 
was then scanned and analyzed on the Nexcelom Celigo.  
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2.18 Basal Stem Cell Differentiation Assay 
Basal cells were seeded into 1:1 GFR matrigel: MTEC plus media into a 24 well plate 
insert. MTEC plus media in the well was changed every 2 days and rock inhibitor was 
omitted after day 4 to allow for differentiation. After 20 days of growth, the media was 
removed and replaced with 4% paraformaldehyde for 24 hours of fixation. The fixed 
matrigel sample was removed and embedded in Histogel, followed by histological 
processing.  
 
2.19 Basal Stem Cell Apoptosis Assay 
Basal cells were plated on top of mitomycin treated J2-3T3 feeders. Using the Annexin 
V/Dead Cell Apoptosis Kit (Thermo Fisher), cells were incubated with reagent and 
subsequently fixed. Analysis was conducted using the Nexcelom Celigo for imaging.  
 
2.20 Distal Lung Stem Cell Isolation Assay 
BASCs and AT2 cells were isolated from ΔNp63fl/fl; RosaM/M mice (Kim et al., 2005, 
Driscoll et al., 2012). After digestion with collagenase and dispase, cells were stained 
with fluorescent antibodies: CD31-APC BD #551262, CD45-APC BD #559864, EpCAM-
PE-Cy7 BioLegend #118216, and SCA-1-APC-Cy7 BD #560654. Cells were sorted in a 
MoFlo Astrios cell sorter. AT2 cells are contained in the CD31neg, CD45neg, 
EpCAMpos  and Sca-1neg population and BASCs, in the CD31neg, CD45neg, 
EpCAMpos and Sca-1pos population. 
 
2.21 Distal Lung Stem Cell Colony Formation Assay 
BASC and AT2 cells were plated in a gelatin coated 96-well plate mixed with primary 
mouse lung endothelial cells in a ratio of 1000 stem cells to 2x106 endothelial cells per 
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plate. Media was changed every 2 days. The plate was analyzed on the Nexcelom 
Celigo after 1 week of culture (Kim et al., 2005) using the colony counting algorithm.  
 
2.22 RNA Isolation 
RNA was extracted using trizol extraction and the Ambion Pure Link RNA mini kit. 10 µl 
of glycogen was added in the wash step to promote isolation of small RNAs. 
 
2.23 TCGA Data Analysis 
The primary and processed data tumor and normal samples were downloaded from The 
Cancer Genome Atlas at (https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp) between 
July 2014 and February 2015. First, RNA-sequencing data for each tumor were quantile 
normalized using R. All differential gene expression and statistical analyses were done 
using the R statistical system.  
 
2.24 Generation of mouse or human signatures  
Approximately 5 µg of polyA+ RNA was used to construct RNA-Seq libraries using the 
standard Illumina protocol. Mouse and human mRNA sequencing yielded 20-40 million 
read pairs for each sample. The mouse mRNA-Seq reads were mapped using TopHat 
v2.0.12 onto the mouse genome mm10 (GRCm38) assembly. Then, mapped reads were 
assembled using cufflinks v2.2.1 in order to calculate the fragments per kilobase of 
transcript per million mapped reads (FPKM). A combined profile of all samples was 
computed. Principal component analysis was executed using the implementation within 
the R statistical analysis system. Hierarchical clustering of samples was executed by first 
computing the symmetrical sample distance matrix using the Pearson correlation 
between mRNA profiles as a metric, supervised sample analysis was performed using 
the t-test statistics, and heat maps were generated using the heatmap.2 package in R.  
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2.25 RNA-seq  
For small RNA library construction, RNA samples were prepared using the DGE-Small 
RNA Sample Prep Kit (Illumina, San Diego, CA) as described previously (16, 17). A total 
of two Solexa-ready small RNA templates were analyzed on an Illumina GA-IIx Genome 
Analyzer at University of Houston. Cluster generation was performed and clusters were 
sequenced. Initial sequence process and analysis was followed as described previously 
(16, 17). Small RNA-Seq sequencing data was uploaded and processed using the 
Genboree Small RNA Toolset (http://genboree.org). The Illumina adapter was trimmed, 
and reads with length between 11 and 30, a copy number of at least 4, and finishing in 
monomers with length less than 10, were selected for further processing, similar to the 
processing described previously (16, 17). The reads were mapped to the mouse 
genome and build UCSC mm9 (NCBI 37) using Pash 3.0(18). Reads mapping up to 100 
locations were selected for further analysis. The miRNA definitions from miRBase (19-
22) were used to construct a known miRNA profile for each sample; the abundance of 
the known miRNAs was normalized as a fraction of the usable reads. For each species, 
a combined profile of all samples was computed; miRNA abundance was mean-
centered and z- score transformed for each miRNA individually. Principal component 
analysis was performed using the implementation within the R statistical analysis 
system. Hierarchical clustering of samples was performed by first computing the 
symmetrical sample distance matrix using the Pearson correlation between microRNA 
profiles as a metric. Supervised sample analysis was performed using the t-test 
statistics, and heat maps were generated using the heatmap.2 package in R.  
 
2.26 Low Cell Number ChIP-seq 
Cells were pelleted and snap-frozen using liquid nitrogen. Low cell number ChIP-seq 
was performed at Active Motif, for wild type and ΔNp63 knockout samples, for H3K27ac, 
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Pol2, and ΔNp63 ChIP-seq. Sequencing was analyzed by HOMER to identify peaks that 
contained the p63 transcription factor binding motif.  
 
2.27 qPCR Analysis 
cDNA was synthesized using Bio-Rad cDNA synthesis kit. qPCR was performed by Bio-
Rad master mix.  
 
2.28 dCas9 Experiments 
Experiments were performed in 293T cells (Wang et al., 2017, Hilton et al., 2015). 
ΔNp63 was cloned into the dCas9 vector. 4 sgRNAs per genomic site were designed 
using the Broad sgRNA design tool. sgRNA sequences were cloned into PLX-sgRNA 
vector. Plasmids for dCas9, dCas9-p300 and dCas9-ΔNp63 were utilized in a 3:1 ratio to 
sgRNA vectors. All plasmids were transfected using Lipofectamine 2000. Cells were 
incubated for 48 hours before collection of the RNA. Gene expression was measured by 
qPCR analysis.   
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3. Chapter 3: Functions of p63 isoforms in basal cell of the trachea. 
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Chapter 3: Functions of p63 isoforms in basal cell of the trachea. 
 
3.1 In vivo ΔNp63 deletion in tracheal epithelium results in expansion and 
depletion of apoptotic Krt5+ basal cells. 
 
To determine the role of ΔNp63 in the normal mouse lung, we crossed the 
ΔNp63fl/fl mice to the Rosa reporter mouse to enable identification of cells that have 
undergone recombination, signified by a switch from tdTomato (red) to GFP (green) 
expression. To specifically target lung epithelium, we performed an intratracheal 
infection of ΔNp63fl/fl; RosaM/M mice with adenoviral cre-recombinase, with adenoviral 
empty vector serving as the control. Histological analysis of the trachea and lung tissues 
of the mice was performed at 1 month and 3 month post-induction time points. 
Immunohistochemical staining for ΔNp63 showed loss of expression in the tracheal 
epithelium of ΔNp63Δ/Δ; RosaΔ/Δ mice but was maintained in control and TAp63Δ/Δ; 
RosaΔ/Δ mice (Figure 4). At 1 month post-induction, quantification of H&E stained 
sections of ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium showed a significant increase of 
stratified epithelium (SE) and epithelial separation (ES) per microscopic field compared 
to the control (Figure 5B). Staining for basal cell marker keratin 5 (Krt5) revealed that the 
make-up of the stratified epithelium in ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium was 
primarily Krt5+ basal cells (Figures 5A) whereas the ad-empty control maintained a 
single basal layer of Krt5+ cells. ΔNp63Δ/Δ; RosaΔ/Δ Krt5+ cells were also significantly 
more positive for Ki67 staining compared to control. At the 3-month time point, the 
majority of the ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium exhibited a hypoplastic epithelial 
(HE) phenotype (Figure 6B) compared to the pseudostratified columnar appearance of 
the control epithelium. Krt5 staining of ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium showed 
decreased abundance of Krt5+ basal cells (Figure 5A), suggesting a depletion or 
exhaustion of basal cells after loss of ΔNp63. To determine the mechanism of loss of 
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basal cells, we stained the epithelium for apoptotic marker, cleaved caspase 3. We 
observed positive staining in the proliferating cells in the 1-month ΔNp63 knockout mice. 
ΔNp63 is highly expressed in the basal cell population of the trachea and basal cells, 
which have been shown to be cells of origin for lung squamous cell carcinoma (Jeong et 
al., 2017). At an extended time point of 6 months post-induction, ΔNp63Δ/Δ tracheal 
epithelium was observed to have a similar flattened phenotype with basement 
membrane separation as the 3-month post-induction time point (Figure 7). This 
phenotype was not observed in the wild type or TAp63 tracheal epithelium. We conclude 
that the ΔNp63 is a critical factor for maintenance of the tracheal basal cell and deletion 
of ΔNp63 results in the loss of self-renewal of the basal cell.  
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Figure 4. ΔNp63 IHC staining of tracheal epithelium 
ΔNp63 immunohistochemical staining of control, ΔNp63Δ/Δ and TAp63Δ/Δ tracheal 
epithelium. ΔNp63Δ/Δ staining was not present in the basal cells of the ΔNp63Δ/Δ 
epithelium but was still detectable in control and TAp63Δ/Δ epithelium.  
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Figure 5: In vivo ΔNp63 deletion in tracheal epithelium results in expansion of 
apoptotic Krt5+ basal cells at the 1 month time point. 
A. ΔNp63fl/fl; RosaM/M and ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium at 1 month post-
induction: H&E, Krt5/GFP, Ki67/GFP, and Casp3/GFP. Scale bar equals 100 µm. 
B.  Quantification of stratified epithelium (SE), hypoplastic epithelium (HE), and epithelial 
separation (ES) for ΔNp63fl/fl; RosaM/M and ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium at 1 
month post-induction.  
A 
B C 
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C. Quantification of immunofluorescence staining of Krt5, Ki67, and Casp3 for ΔNp63fl/fl; 
RosaM/M and ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium at 1 month post-induction. 
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Figure 6. In vivo ΔNp63 deletion in tracheal epithelium results in loss of apoptotic 
basal cells at the 3 month time point. 
A. ΔNp63fl/fl; RosaM/M and ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium at 3 months post-
induction: H&E, Krt5/GFP, Ki67/GFP, and Casp3/GFP. Scale bar equals 100 µm. 
B. Quantification of stratified epithelium (SE), hypoplastic epithelium (HE), and epithelial 
separation (ES) for ΔNp63fl/fl; RosaM/M and ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium at 3 
months post-induction. 
C. Quantification of immunofluorescence staining of Krt5, Ki67, and Casp3 for ΔNp63fl/fl; 
RosaM/M and ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium at 3 months post-induction.  
 
 
A 
B C 
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Figure 7. Comparison across time points and genotypes of tracheal epithelium.  
H&E images of tracheal epithelium of wild type control, ΔNp63Δ/Δ and TAp63Δ/Δ mice 
across 1 month, 3 month and 6 month time points. Wild type control epithelium retains 
the pseudostratified columnar architecture of the tracheal epithelium at all time points. 
The epithelium of the ΔNp63Δ/Δ mouse demonstrates a stratified disorganized epithelium 
at 1 month, followed by a simplified epithelium at 3 and 6 months. The TAp63Δ/Δ 
epithelium has similar architecture to the wild type control.  
 
 
 
 
 
 28 
3.2 ΔNp63 is required for basal cell differentiation in vivo. 
 
As ΔNp63 has been shown to regulate differentiation of stem cells, we asked if 
ΔNp63-depleted basal cells are able to differentiate into ciliated and goblet cells. To 
determine the differentiation ability of ΔNp63Δ/Δ basal cells in vivo, we administered a 
polidocanol challenge to ΔNp63fl/fl; RosaM/M mice after adeno-cre to remove suprabasal 
tracheal epithelial cells, leaving a monolayer of basal cells (Figure 8). While the wild type 
basal cells were able to differentiate into goblet (muc5ac) and ciliated cells (acetylated 
tubulin) of the tracheal epithelium 1 week after the polidocanol challenge with a 
pseudostratified columnar structure of the epithelium (Figure 9A), we observed that the 
ΔNp63Δ/Δ tracheal epithelial forming a stratified epithelium (Figure 10B) of Krt5+ cells 
(Figure 9B and 9D) that are highly proliferative (Figure 9J) with elevated markers of cell 
death (Figure 9L). This data suggests that the proliferation of ΔNp63Δ/Δ tracheal 
epithelium at the 1 month time point is primarily due to basal cell proliferation and not a 
compensatory dedifferentiation of the ciliated or goblet cells. ΔNp63Δ/Δ mice also 
exhibited higher mortality after polidocanol treatment compared to ΔNp63fl/fl mice, with 
50% mortality within 4 days of polidocanol treatment, suggesting a decreased ability to 
maintain a functional tracheal epithelium. We examined the tracheal epithelium at 1 
month after polidocanol administration and found that the ΔNp63Δ/Δ mice treated with 
polidocanol had a thin, hypoplastic epithelium lacking Krt5+ cells (Figures 10B and 10D), 
similar to the three-month time point of the ΔNp63Δ/Δ mice, suggesting that polidocanol 
treatment depleted the basal cell population. This data demonstrates the importance of 
ΔNp63 for maintenance of tracheal epithelial integrity though regulation of basal cell self-
renewal and differentiation.  
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Figure 8. Schematic of polidocanol tracheal injury experiment to determine if 
ΔNp63 is required for basal cell differentiation in vivo.  
6-8 week old mice were intratracheally instilled with either adeno-empty or adeno-cre. 
After 72 hours to allow for recombination, mice were again intratracheally instilled with 
either polidocanol or PBS. Mice were analyzed at the 7 day time point (time point 1) and 
after 30 days (time point 2). 
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Figure 9. ΔNp63 deletion impairs tracheal epithelial basal cell differentiation. 
(A, C, E, G, I, K) ΔNp63fl/fl; RosaM/M tracheal epithelium after polidocanol (PDO) 
treatment: H&E (A), Krt5/GFP (C), Ac-tub/GFP (E), Muc5ac/GFP (G), Ki67/GFP (I) and 
Casp3/GFP (K). Scale bar equals 100 µm. 
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(B, D, F, H, J, L) ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium after polidocanol (PDO) 
treatment: H&E (B), Krt5/GFP (D), Ac-tub/GFP (F), Muc5ac/GFP (H), Ki67/GFP (J) and 
Casp3/GFP (K). Scale bar equals 100 µm. 
 
(M) Quantification of staining for time point 1. 
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Figure 10. ΔNp63 deletion results in exhaustion of Krt5+ basal cells in polidocanol 
tracheal injury model.  
(A, C, E, G, I, K) ΔNp63fl/fl; RosaM/M tracheal epithelium after polidocanol (PDO) 
treatment: H&E (A), Krt5/GFP (C), Ac-tub/GFP (E), Muc5ac/GFP (G), Ki67/GFP (I) and 
Casp3/GFP (K). Scale bar equals 100 µm. 
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(B, D, F, H, J, L) ΔNp63Δ/Δ; RosaΔ/Δ tracheal epithelium after polidocanol (PDO) 
treatment: H&E (B), Krt5/GFP (D), Ac-tub/GFP (F), Muc5ac/GFP (H), Ki67/GFP (J) and 
Casp3/GFP (K). Scale bar equals 100 µm. 
 
(M) Quantification of staining for time point 2. 
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3.3 ΔNp63 is necessary for maintenance and differentiation of basal cells in vitro. 
 
To further investigate the mechanism of ΔNp63 in maintenance of basal cells, we 
isolated basal cells from ΔNp63fl/fl; RosaM/M mouse tracheas, cultured them in vitro, and 
infected the cells with either adeno-empty or adeno-cre to knock out ΔNp63. We found 
that ΔNp63Δ/Δ basal cell colonies replicated in vivo proliferation patterns as early 
passage cells were more proliferative (Figure 12B) and late passage cells less 
proliferative compared to the wild type basal cells (Figure 12C). To investigate the effect 
of ΔNp63 loss on self-renewal, we cultured basal cells in a 3D medium. We found that 
the ΔNp63Δ/Δ cells formed significantly fewer spheres (Figure 14D) that were also smaller 
in size (Figure 14E). The number and size of spheres formed by ΔNp63Δ/Δ also 
decreased across passages. This effect was magnified by the passaging of the basal 
cells, as later passages of wild type basal cells exhibited increased sphere formation 
ability, suggesting a selection effect where a small percentage of wild type basal cells 
that were not infected by the adeno-cre outcompeted ΔNp63Δ/Δ basal cells across 
multiple passages. To examine ΔNp63’s role in basal cell differentiation, we 
differentiated basal cells in matrigel for 20 days (Rock et al., 2009). While the wild type 
basal cells formed hollow bi-layered spheres (Figure 15F and 15G) containing an outer 
layer of basal cells (Figure 15H) and an interior of ciliated and goblet cells (Figures 15J 
and 15K), ΔNp63Δ/Δ basal cells formed smaller, mono-layered spheres (Figures 15L and 
15M) that lacked staining for differentiation markers Ac-tub and Muc5ac. While the 
ΔNp63Δ/Δ spheres lacked staining for basal cell marker Krt5 (Figure 15N), an alternative 
marker for basal cells NGFR was expressed (Figure 15O). Our data support a role of 
ΔNp63 in regulation of basal cell maintenance and differentiation.  
 
 
 
 35 
 
 
 
 
 
 
 
Figure 11. ΔNp63Δ/Δ basal cells form smaller colonies in 2D culture.  
 
Basal cells isolated from mouse tracheal epithelium were infected with adenoviral-empty 
or adenoviral-cre and plated onto mitomycin-treated J2-3T3 feeders. ΔNp63fl/fl colonies 
(red fluorescence) were larger and more numerous than ΔNp63Δ/Δ colonies (green 
fluorescence). 
 
 
 
 
 
 
ΔNp63Δ/Δ; RosaΔ/Δ ΔNp63fl/fl; RosaM/M 
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Figure 12. Basal cell colonies exhibit transient proliferative burst followed by 
decrease of proliferation after deletion of ΔNp63. 
(A-C) EdU assay measuring proliferation of ΔNp63fl/fl and ΔNp63Δ/Δ colonies across 
passages 1 (A), 2 (B), and 3 (C).  
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Figure 13. ΔNp63Δ/Δ basal cell colonies exhibit increased apoptosis.  
Annexin V assay measuring apoptosis in ΔNp63fl/fl and ΔNp63Δ/Δ colonies across 
passages 1-3. 
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Figure 14. ΔNp63Δ/Δ basal cells have decreased sphere formation and sphere size.  
(A, B) Representative wells of tracheosphere formation assay of ΔNp63fl/fl (A) and 
ΔNp63Δ/Δ (B) basal cells at passage 3.  
 
(C, D) Tracheosphere formation assay (C) and tracheosphere size (D) of ΔNp63fl/fl and 
ΔNp63Δ/Δ basal cells across passages 1-3. 
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Figure 15. ΔNp63Δ/Δ tracheospheres have impaired ability to differentiate.  
Tracheosphere differentiation assay for ΔNp63fl/fl and ΔNp63Δ/Δ basal cells: H&E (A and 
G), scale bar equals 100 um. H&E (B and H), Krt5/GFP (C and I), NGFR/GFP (D and J), 
Ac-tub/GFP (E and K), Muc5ac/GFP (F and L), scale bar equals 20 um. 
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Figure 16. Differences in sphere formation numbers or size were not observed 
with TAp63Δ/Δ basal cells compared to wild type basal cells. 
A. TAp63Δ/Δ basal cells sphere formation in 3D culture was not significantly changed 
compared to wild type basal cells.  
B. TAp63Δ/Δ basal cells sphere size measured by area in 3D culture was not significantly 
changed compared to wild type basal cells.  
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3.4 ΔNp63 regulates cell identity genes in basal cells. 
 
To further probe the transcriptional network of genes regulated by ΔNp63 in basal 
cells, we isolated basal cells to perform RNA-seq and ChIP-seq (Figure 17A). Basal cells 
from ΔNp63fl/fl; RosaM/M mice were expanded on feeders, infected with either adeno-
empty or adeno-cre, expanded again on feeders, and then collected for RNA-seq, 
miRNA-seq or ChIP-seq. Principle component analysis showed concordance between 
wild type and ΔNp63Δ/Δ samples (Figure 18), as did generated heat maps for the RNA-
seq and miRNA-seq (Figures 19 and 20). Ingenuity Pathway Analysis of the miRNA-seq 
data showed a network for genes regulated by upregulated and downregulated miRNAs 
(Figure 21). Pathway analysis in the RNA-seq data showed that major pathways affected 
after loss of ΔNp63 included those involved in proliferation, stem cell maintenance, and 
adhesion (Figure 17B). Genes involved in epithelialization and cell junction maintenance 
were downregulated in ΔNp63Δ/Δ samples (Figure 17C). To characterize genome-wide 
ΔNp63 binding sites in this primary stem cell population, we utilized a method of perform 
low-cell number ChIP-seq. ChIP-seq using an antibody against p63 allowed us to 
generate a p63 binding motif that is similar to previously published p63 motifs (Figure 
17D). The distribution of basal cell ChIP-seq peaks with regards to genomic features 
shows changes mostly in the intergenic and 10 kb upstream regions (Figure 22). 
Recently, it has been shown that cell identify genes are often regulated by 
enhancers and super-enhancers which are marked by H3K27ac (Whyte et al., 2013, 
Loven et al., 2013). To determine the effect of ΔNp63 loss on enhancers and super-
enhancers (a cluster of enhancers), we performed ChIP-seq for H3K27ac along with 
Pol2. Loss of ΔNp63 affected genome wide H3K27ac and Pol2 occupancy, especially at 
super-enhancers (Figures 23-27). ChIP-seq peaks showed that there was a loss of 
H3K27ac signal at Krt5 and BCL9L after deletion of ΔNp63 (Figure 17F). Our data 
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indicate that ΔNp63 regulates basal cells through regulating transcription of super-
enhancer associated cell identity genes.  
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Figure 17. ΔNp63 regulates cell identity genes in basal cells. 
(A) Schematic of isolation of ΔNp63fl/fl and ΔNp63Δ/Δ basal cells for RNA-seq and ChIP-
seq. 
 
(B) Pathway analysis of RNA-seq based on differentially expressed genes between 
ΔNp63fl/fl and ΔNp63Δ/Δ basal cells. 
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(C) qPCR validation of ΔNp63-regulated genes in basal cells.  
 
(D) p63 motif derived from basal cell p63 ChIP-seq compared to published p63 motif.  
 
(E) Super-enhancer curve based on H3K27ac ChIP-seq ΔNp63fl/fl (blue) and ΔNp63Δ/Δ 
(red) basal cells 
 
(F) H3K27ac ChIP-seq signal area under peak for top 500 enhancers in basal cells. 
 
(G) H3K27ac ChIP-seq signal area under peak for top 5000 enhancers in basal cells. 
 
(H) ChIP-seq profiles for H3K27ac in ΔNp63fl/fl (red) and ΔNp63Δ/Δ (pink) basal cells for 
genes Krt5 and BCL9L. 
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Figure 18: PCA analysis of RNA-seq and miRNA-seq samples for basal cells. 
Principle component analysis (PCA) of basal cell RNA-seq (A) demonstrates clustering 
of ΔNp63Δ/Δ samples (SJW.RNA_CRE.1-3) compared to ΔNp63fl/fl samples. miRNA-seq 
(B) PCA of ΔNp63fl/fl(flfl) and ΔNp63Δ/Δ(DD) samples. 
A. 
B. 
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Figure 19. Heat map of RNA-seq from ΔNp63fl/fl and ΔNp63Δ/Δ basal cells.  
Differential gene expression of downregulated (red) and upregulated (green) genes of 
ΔNp63fl/fl(WT) and ΔNp63Δ/Δ(CRE) basal cells. 
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Figure 20. Heat map of miRNA-seq from ΔNp63fl/fl and ΔNp63Δ/Δ basal cells.  
Differential gene expression of downregulated (red) and upregulated (green) genes of 
ΔNp63fl/fl(FLFL) and ΔNp63Δ/Δ(D.D.) basal cells. 
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Figure 21. ΔNp63 controls miRNA-mRNA network of basal cells.  
Pathway analysis of genes regulated by ΔNp63-regulated miRNAs. 
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Figure 22. Distribution of basal cell ChIP-seq peaks with regards to genomic 
features.  
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Figure 23. Signal comparison at the transcription start site (TSS) for ΔNp63 wild 
type and knockout basal cells.  
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Figure 24. Signal comparison of H3K27ac ChIP-seq at enhancers for ΔNp63 wild 
type and knockout basal cells. 
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Figure 25. Signal comparison of Pol2 ChIP-seq at enhancers for ΔNp63 wild type 
and knockout basal cells. 
 
 
 
 
 
 
 
 
 
 
 53 
 
 
Figure 26. Signal comparison of H3K27ac ChIP-seq at super-enhancers for ΔNp63 
wild type and knockout basal cells. 
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Figure 27. Signal comparison of Pol2 ChIP-seq at super-enhancers for ΔNp63 wild 
type and knockout basal cells.  
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4. Chapter 4: Functions of p63 isoforms in stem cells of the distal lung. 
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Chapter 4: Functions of p63 isoforms in stem cells of the distal lung. 
To profile the role of ΔNp63 in the distal lung, we profiled the lungs of ΔNp63fl/fl; 
RosaM/M and ΔNp63Δ/Δ; RosaM/M mice for AT2 cell marker SPC. Though we observed 
slight increases of SPC+ cells at 1 month and decreases at 3 months in the ΔNp63 ad-
cre treated mice, the changes were not significantly different (Figure 28). 
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Figure 28. Distal lung shows few differences between ΔNp63fl/fl; RosaM/M and 
ΔNp63Δ/Δ; RosaΔ/Δ distal lung 1 and 3 months post-induction 
ΔNp63fl/fl; RosaM/M and ΔNp63Δ/Δ; RosaΔ/Δ lung 1 and 3 months post-induction: H&E and 
SPC/GFP. Add Scale bar equals 100 µm. 
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As we observed a role of ΔNp63 in initiation of lung adenocarcinoma, we also 
aimed to profile distal lung stem cells. We also isolated AT2 and BASC cells from 
ΔNp63fl/fl; RosaM/M (Figure 29A). In a colony formation assay, ΔNp63Δ/Δ AT2 and BASC 
exhibited decreased colony formation (Figure 29B and 29C). To determine the effect of 
ΔNp63 loss in regulating enhancers and super-enhancers, we performed H3K27ac 
ChIP-seq in AT2 cells from ΔNp63fl/fl; RosaM/M mice. Similar to basal cells, ChIP-seq for 
H3K27ac also showed a global decrease of marks after loss of ΔNp63 (Figure 29D and 
29E). Ranking of genes based on H3K27ac signal identified super-enhancer associated 
genes in AT2 cells that had decreased expression after loss of ΔNp63 (Figure 29F and 
29G). ETV5 was recently identified as an essential gene for maintenance of the AT2 cell 
population and was identified in our analysis as significantly decreased after loss of 
ΔNp63. ChIP-seq peaks show that there is a loss of H3K27ac signal at ETV5 and 
BCL9L after deletion of ΔNp63 (Figure 29H and 30). Our results suggest that ΔNp63 
also regulates cell identity gene expression in the distal lung stem cell population. 
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Figure 29. ΔNp63 regulates stemness in distal lung stem cells. 
(A) Schematic of isolation of ΔNp63fl/fl and ΔNp63Δ/Δ AT2 cells and BASC cells for RNA-
seq and ChIP-seq. 
 
(B-C) Colony formation assay for ΔNp63fl/fl and ΔNp63Δ/Δ AT2 cells and BASCs (B) with 
quantification (C). 
 
(D-E) Signal histogram for ΔNp63fl/fl and ΔNp63Δ/Δ AT2 cell H3K27ac ChIP-seq (D) with 
calculation of area under the curve (E).  
 
(F) Super-enhancer curve based on H3K27ac ChIP-seq ΔNp63fl/fl (blue) and ΔNp63Δ/Δ 
(red) AT2 cells 
 
(G) qPCR validation of ΔNp63-regulated genes in AT2 cells.  
 
(J) ChIP-seq profiles for H3K27ac in ΔNp63fl/fl (red) and ΔNp63Δ/Δ (pink) AT2 cells for 
genes ETV5 and BCL9L. 
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Figure 30. Distribution of AT2 cell ChIP-seq peaks with regards to genomic features. 
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5. Chapter 5: ΔNp63 in lung tumorigenesis. 
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Chapter 5: ΔNp63 in lung tumorigenesis. 
 
Our lab recently utilized a keratinocyte-derived signature of ΔNp63-regulated 
genes to assign a putative oncogenic role to ΔNp63 in the context of lung squamous cell 
carcinoma (LUSC) and lung adenocarcinoma (LUAD)(Abbas et al., 2018). The 
designation of ΔNp63 as an oncogene in LUSC was not surprising, as ΔNp63 is highly 
amplified in LUSC (Cancer Genome Atlas Research, 2012) and has been utilized as a 
positive diagnostic marker for LUSC (Conde et al., 2010). However not much is known 
about ΔNp63’s role in LUAD, as ΔNp63 is often used as a negative marker for the 
diagnosis of LUAD. To interrogate whether ΔNp63 functions as an oncogene in the 
context of LUSC, we utilized shRNAs to knock down ΔNp63 in human LUSC cell lines 
H520 and H2170. To determine the effect of ΔNp63 on anchorage-independent growth, 
H520 and H2170 cell lines were grown in a soft agar assay. H520 and H2170 stably 
transfected with shΔNp63 formed significantly fewer colonies than shControl cell lines 
(Figures 31C and 31D). H520 and H2170 shΔNp63 cell lines also formed significantly 
smaller flank tumors in xenograft mice compared to shControl cell lines (Figures 31A 
and 31B), with almost complete absence of tumor formation in the H2170 shΔNp63 cell 
line, demonstrating a potent ability for ΔNp63 inhibition to decrease tumor growth in vivo. 
ΔNp63 knockdown tumors had decreased proliferation (Figures 31F and 31J) and 
increased staining for apoptotic marker cleaved caspase-3 (Figures 31H and 31L). Our 
data support ΔNp63’s oncogenic role in the context of LUSC through maintenance of 
anchorage independent growth and inhibition of cell death. 
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Figure 31. ΔNp63 promotes tumor initiation and progression in human lung 
squamous cell carcinoma cell line. 
(A and B) Comparison of colony formation in soft agar of LUSC cell line (A) H520 
shControl and shΔNp63 and (B) H2170 shControl and shΔNp63. 
 
(C and D) Comparison of tumor volume of xenografted LUSC cell line (C) H520 
shControl and shΔNp63 (n=11) and (D) H2170 shControl and shΔNp63 (n=8).  
 
(E-L) Representative images of xenograft tumors for H520 shControl and shΔNp63 for 
H&E (E and I), Ki67 (F and J), ΔNp63 (G and K), and Casp3 (H and L). Scale bar equals 
100 µm. 
 
(M) Quantification of immunohistochemical staining for Figure 1 F-H and J-L. 
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To determine the role of ΔNp63 in lung adenocarcinoma, we generated a new 
mouse model by crossing the LSLKrasG12D mouse to the ΔNp63 conditional knockout 
mouse (Chakravarti et al., 2014) and inducing recombination through intratracheal 
administration of adenoviral Cre recombinase (DuPage et al., 2009) with robust 
recombination efficiency in the trachea and lung parenchyma. When examining a time 
point of 20 weeks post-induction with adenoviral cre, Lox-KrasG12D mice formed lung 
adenomas as previously reported (Jackson et al., 2001) (Figure 32A). In comparison, the 
lungs in compound ΔNp63Δ/Δ; Lox-KrasG12D mice had a significant decrease of lung 
adenoma formation (Figure 32A). Examination and grading of the lung lesions(Jackson 
et al., 2001) revealed significantly fewer lesions of all grades (atypical adenomatous 
hyperplastic lesions, grade 1, grade 2+) in ΔNp63Δ/Δ; Lox-KrasG12D mice compared to 
Lox-KrasG12D mice (Figure 32B). Interestingly, tumors from Lox-KrasG12D mice stained 
positive for ΔNp63 while ΔNp63Δ/Δ; Lox-KrasG12D lesions were negative (Figures 32E and 
32F). Non-tumorigenic lung epithelium does not have detectable levels of ΔNp63, 
suggesting the increase may be a result of activation from the mutant Kras driver.  
We also investigated how ΔNp63 and TAp63 could affect tumorigenesis of 
mutant p53 driven cancer. We crossed the ΔNp63fl/fl and TAp63fl/fl mice with 
LSLp53R172H/+ mice and observed a general decrease of tumorigenesis of grade 2+ 
lung lesions but no significant difference in AAH or grade 1 lesions (Figure 33). 
Our results provided evidence for an unexpected role of ΔNp63 in the initiation 
and development of lung adenocarcinoma lesions.  
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Figure 32. ΔNp63 promotes tumor initiation and progression in a mouse model of 
lung adenocarcinoma.  
(A) Representative lung lobes from Lox-KraxsG12D and ΔNp63Δ/Δ; Lox-KrasG12D mice. 
Scale bar equals 3 mm. 
 
(B) Lung tumor grading of Lox-KrasG12D and ΔNp63Δ/Δ; Lox-KrasG12D mice grouped by 
lesions per mouse for categories of atypical adenomatous hyperplasia (AAH), Grade 1, 
and Grade 2+. 
 
(C-F) Representative images of lung lesions from Lox-KrasG12D and ΔNp63Δ/Δ; Lox-
KrasG12D mouse: H&E (P and Q) and ΔNp63 (R and S) respectively. Scale bar equals 
100 µm.  
 
(G and H) Representative staining for CCSP and SPC in lung adenoma from Lox-
KrasG12D mouse (T) and ΔNp63Δ/Δ; Lox-KrasG12D mouse (U). Scale bar equals 100 µm. 
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(I) Soft agar assay in LUAD cell lines H1944, H358, and H2009 with siControl and 
siΔNp63 knockdown.  
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Figure 33. Tumor spectrum of LSLp53R172H/+ mice crossed with p63 isoform 
conditional knockout mice.  
Analysis of lungs from LSLp53R172H/+, ΔNp63Δ/Δ; LSLp53R172H/+, and TAp63Δ/Δ; 
LSLp53R172H/+ scored for atypical adenomatous hyperplasia (AAH), grade 1 and 
grade 2+ lesions.  
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6. Chapter 6: Epigenetic mechanisms of ∆Np63 in tumorigenesis 
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Chapter 6: Epigenetic mechanisms of ∆Np63 in tumorigenesis 
 
ΔNp63 coordinates with p300 to regulate oncogenic super-enhancer associated 
genes in human cancer cell lines. 
 
After analyzing the super-enhancer signatures from AT2 cells and basal cells, we 
found a list of AT2-specific, basal-specific, and common genes regulated by ΔNp63 
(Figure 34A). To enable translation into human samples, we cross-referenced the 
identified genes with H3K27ac ChIP-seq data from human lung cancer cell lines. We 
located super-enhancers in each of these data sets and identified genes located near 
super-enhancer regions, which also contained a p63-binding motif. Genes that met 
these criteria were crosschecked with the LUAD and LUSC TCGA databases for 
alterations in cancer. As we hypothesized ΔNp63’s primary contribution to tumorigenesis 
as through maintenance of stem cell renewal and differentiation pathways, we focused 
on genes that were reported to have functions in stem cell biology. In the end, we 
focused on Krt5 as the basal cell specific gene, ETV5 as the AT2 specific gene, and 
BCL9L as the common gene.  
 
To determine whether ΔNp63 regulates super-enhancers, we co-targeted ΔNp63 
and the histone acetyltransferase p300 to several super-enhancer regions in which 
H3K27ac signals were reduced by ΔNp63 by employing a deactivated Cas9 (dCas9) 
targeting strategy (ref). We transfected 293T cells with vectors expressing dCas9-
conjugated proteins p300 and ΔNp63 to target these proteins to super-enhancer regions 
with a p63 motif (Figure 34B). In addition, we co-transfected 4 sgRNAs per region of 
super-enhancers for Krt5, ETV5, and BCL9L into 293T cells. We found that while dCas9-
p300 alone had no significant effect on gene expression. dCas9-ΔNp63 recruitment to a 
super-enhancer p63 motif significantly increased gene expression (Figures 34C-34E). 
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The combination of dCas9-ΔNp63 and dCas9-p300 recruitment further increased gene 
expression significantly over dCas9-ΔNp63 alone, demonstrating an additive effect of 
ΔNp63 and p300 to induce gene expression.  
 
To ask whether ΔNp63 and p300 co-localize at p63 motifs located in super-
enhancer regions, we performed chromatin immunoprecipitation in the H520 cell line 
which expresses high levels of ΔNp63, comparing shcontrol and shΔNp63 cell lines. We 
found that occupancy levels of H3K27ac, p300 and ΔNp63 at ETV5, BCL9L, and Krt5 
genes significantly decreased in shΔNp63 cells compared to shControl cells (Figures 
34F-34H), supporting a mechanism for ΔNp63 and p300 co-recruitment at p63 motifs to 
promote histone acetylation in enhancer regions.  
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Figure 34. ΔNp63 coordinates with p300 to regulate oncogenic super-enhancer 
associated genes in human cancer cell lines. 
 
(A) Venn diagram overlaying ΔNp63-regulated super-enhancer associated genes in AT2 
cells and basal cells. 
 
(B) Schematic of dCas9-p300 and dCas9-ΔNp63 sgRNA experiment.  
 
(C-E) Relative change in gene expression at the p63 binding motif of ETV5 (C), BCL9L 
(D), and KRT5 (E) genes in 293T cells after transfection with dCas9 elements.  
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(F-H) Quantitative ChIP assay in H520 shControl and shΔNp63 cells for p300, H3K27ac, 
and ΔNp63 occupancy at the p63 motif of genes ETV5 (F), BCL9L (G), and Krt5 (H).  
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To understand the functional roles of these genes, we used shRNA to 
knockdown expression of BCL9L, KRT5, and ETV5 in LUSC cell line H520 and LUAD 
cell line H358 (Figure 35). In an in vitro soft agar assay, we found that knocking down 
common gene BCL9L and basal cell gene Krt5 significantly reduced colony formation in 
LUSC cell line H520, whereas knock down of AT2 cell gene ETV5 did not produce a 
significant effect.  
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Figure 35. Tumor type specific effects of basal cell or AT2 cell gene knockdown.  
Soft agar assay in LUSC cell line H520 and LUAD cell line H358 were transfected with 
shControl, shBCL9L, shKRT5, and shETV5. While both cell lines show colony formation 
inhibition on knockdown of common gene BCL9L, there is a selective effect for the basal 
cell gene (Krt5) and AT2 cell gene (ETV5). In the LUSC cell line H520, knockdown of 
basal cell gene Krt5 produces a decrease in colony formation but there is no significant 
effect of shETV5. Conversely in LUAD cell line H358, knockdown of AT2 gene ETV5 
decreases colony formation while knockdown of basal cell gene Krt5 shows no 
significant difference from control.  
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Similarly, knocking down common gene BCL9L and AT2 gene ETV5 significantly 
reduced colony formation in LUAD cell line H358, whereas knock down of basal cell 
gene KRT5 did not produce a significant effect. H520 and H358 shBCL9L cell lines also 
formed significantly smaller flank tumors in xenograft mice compared to shControl cell 
lines (Figure 36). 
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Figure 36. BCL9L knockdown in human lung cancer cell lines.   
Comparison of tumor volume of xenografted LUSC cell line (A) H520 shControl and 
shBCL9L (n=5) and H358 LUAD cell line (B) shControl and shBCL9L (n=5).  
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Figure 37. A hypothetical model.  
A hypothetical model showing how loss of ΔNp63 leads to a decrease of histone 
acetylation and gene expression at ΔNp63-regulated genes. 
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7. Chapter 7: Discussion, Conclusions and Future Directions 
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Chapter 7: Discussion, Conclusions and Future Directions  
  
 The molecular understanding of lung cancer initiation and progression is 
complex. As new molecular targets are identified for treatment, there remains the 
exciting possibility to use identified targets for therapeutics and diagnostics. The findings 
of my thesis would provide new insights into the mechanisms underlying the biology of 
lung cancer, through determining a novel function of the transcription factor ΔNp63 to 
regulate cell identity genes in lung stem cells that also have roles in tumor maintenance.  
 
 We have shown that ΔNp63 acts in a pro-tumorigenic role in both lung squamous 
cell carcinoma and lung adenocarcinoma. ΔNp63’s role in lung squamous carcinoma 
has been well documented as a diagnostic marker. Indeed, ΔNp63 has been shown to 
have high sensitivity and specificity for distinguishing lung squamous cell carcinoma 
from lung adenocarcinoma, though there are subsets of lung adenocarcinomas that stain 
positive for ΔNp63. In human squamous cell carcinoma cell lines, we showed that 
knockdown of ΔNp63 significantly inhibited in vivo tumor growth, through inhibition of cell 
proliferation and activation of apoptotic processes. We also demonstrate a previously 
unidentified role of ΔNp63 in lung adenocarcinoma initiation and progression.  
 
Our findings also address the role of p63 isoforms in regulation of lung stem 
cells. We found that ΔNp63 is the primary isoform that regulates the maintenance and 
differentiation of tracheal basal stem cells, and to a lesser extent AT2 cells, in the 
mouse, through regulation of cell identity genes. We suggest that ΔNp63 is a critical 
regulator for lung stem cell self-renewal and differentiation, controlling important growth 
and signaling pathways that may also be essential for basal cells and AT2 cells to 
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transform into cancerous precursors of lung squamous cell carcinoma and 
adenocarcinoma, respectively.  
 
ΔNp63’s role in the distal lung has been implicated by several groups, though 
their studies have primarily focused on transiently amplified distal lung stem cells that 
are positive for p63 that arise after lung injury. Our data here suggests a novel 
mechanism for ΔNp63’s role in AT2 cells as we have isolated the specific cell type of 
AT2 to perform our genetic deletion of ΔNp63. Our mouse model of ΔNp63-LOX-Kras is 
also a unique approach to identify a tumor initiating role of ΔNp63, presumably through 
its role in regulation of stem cell signaling pathways that are often co-opted in cancer, 
such as BCL9L. This suggests that ΔNp63 plays a critical role in the initiation and 
beginning stages of cancers that are derived from stem cells that require ΔNp63, such 
as skin, breast, bladder etc.  
 
Our discovery of the role of ΔNp63 in regulation of super-enhancer associated 
genes shows that ΔNp63 acts as a key transcription factor at enhancer sites to increase 
gene expression. We have shown this both through ChIP in human cancer cell lines and 
in an alternative exogenous system utilizing dCas9 technology. As super-enhancer 
associated genes are increasingly identified as key drivers of individual tumor biology, 
the targeting of these genes may be key to effective treatment strategies. Increased 
knowledge about the cell signaling pathways that are essential for cancer initiation and 
progression are important for the development of new diagnostic and therapeutic 
modalities.  
 
Previous work in our lab has demonstrated the therapeutic feasibility of targeting 
ΔNp63 in cancer cells. Venkatanarayan et al demonstrated that deletion of ΔNp63 in the 
 82 
context of thymic lymphoma can upregulate IAPP metabolic pathways to induce 
apoptosis of the cell (Venkatanarayan et al., 2015). Interestingly, IAPP has an FDA-
approved synthetic analog, Pramlintide, which functioned to induce tumor cell apoptosis 
in a similar way as deletion of ΔNp63. Napoli et al identified a novel mechanism to target 
ΔNp63 protein stability by HDAC inhibitors (Napoli et al., 2016). My work contributes 
further to support the therapeutic strategy of targeting ΔNp63, due to its role in regulation 
of genes that are key to the function of the cell of origin and are maintained in the 
development of the cancer.  
 
The work described here can be extended to future studies, as described in the 
subsequent text. In understanding ΔNp63’s role in stem cell biology, we identified an 
extensive list of genes that are regulated by ΔNp63 in both basal cells and distal lung 
stem cells. These genes can be further queried to more deeply understand how ΔNp63 
maintains the stem cell function. As we have shown that ΔNp63 loss inhibited lung 
adenoma formation in the mutant Kras mouse model, we are also interested whether 
this is true in a mouse model of lung squamous cell carcinoma. Mouse models for lung 
squamous cell carcinoma have not been able to recapitulate the human disease. One 
approach to understanding if ΔNp63 is required for initiation of lung squamous cell 
carcinoma would be to cross the ΔNp63fl/fl mouse to existing lung squamous cell 
carcinoma mouse models. Likewise, the reverse experiment could be performed which 
is to over-express ΔNp63 in the lung to observe for increased tumor formation.  
 
Further work can explore if the effectiveness of therapeutically inhibiting ΔNp63 
in lung cancer. From previous work in the lab, Pramlintide or HDAC inhibitors could be 
used to treat human lung cancer cell lines or mouse models of lung cancer. As a major 
issue of lung cancer mortality is due to a lack of sensitive detection methods, 
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understanding the early molecular changes that lead to lung cancer could be a strategy 
to screen for pre-neoplastic lesions in patients, enabling for the determination of patients 
that require enhanced screening or early treatment.  
 
We propose that ΔNp63 is a master transcription factor in regulation of lung stem 
cell populations as it regulates genome accessibility of cell-identity genes that are 
important for promotion of lung cancer initiation and progression. We hope that this 
discovery provides important new insights about the role of ΔNp63 in the lung and 
mechanistic insight into how inhibition of ΔNp63 works to inhibit tumorigenesis.  
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Appendix 1. Oligonucleotide table 
Primer Name Sequence Function 
GAPDH-F 
 
TCA CCA CCA TGG AGA AGG C 
 
Mouse qRT-PCR for GAPDH 
GAPDH-R 
 
GCT AAG CAG TTG GTG GTG CA 
 
Mouse qRT-PCR for GAPDH 
mETV5-F 
 
TCA GTC TGA TAA CTT GGT GCT TC 
 
Mouse qRT-PCR for ETV5 
mETV5-R 
 
GGC TTC CTA TCG TAG GCA CAA 
 
Mouse qRT-PCR for ETV5 
mBCL9L-F 
 
AGC AGC ACC TAA TGG GCA AAG 
 
Mouse qRT-PCR for BCL9L 
mBCL9L-R 
 
GGA TAA GTC GAA CTC AGG AAT GC 
 
Mouse qRT-PCR for BCL9L 
DNp63F1 
 
CAA AAC CCT GGA AGC AGA AA 
 
Mouse qRT-PCR for ΔNp63 
TA&DNp63R1 
 
GAG GAG CCG TTC TGA ATC TG 
 
Mouse qRT-PCR for ΔNp63 
mTead4-F 
 
TGG ACA TCC GCC AAA TCT ATG 
 
Mouse qRT-PCR for Tead4 
mTead4-R 
 
CCC AGA ACT TCA CAA GGA AGA A 
  
CCC AGA ACT TCA CAA GGA AGA A 
 
CCC AGA ACT TCA CAA GGA AGA A 
 
Mouse qRT-PCR for Tead4 
mDSP-F 
 
GCT GAA GAA CAC TCT AGC CCA 
 
Mouse qRT-PCR for DSP 
mDSP-R 
 
ACT GCT GTT TCC TCT GAG ACA 
 
Mouse qRT-PCR for DSP 
mPPP1R13L-F 
 
GCC TAC GAG AAA AAG TCT TCA CA 
 
Mouse qRT-PCR for 
PPP1r13L mPPP1R13L-R 
 
CTC TCT CCA GGG TAA GAG CTG 
 
Mouse qRT-PCR for 
PPP1r13L mKrt5-F 
 
TCT GCC ATC ACC CCA TCT GT 
 
Mouse qRT-PCR for Krt5 
mKrt5-R 
 
CCT CCG CCA GAA CTG TAG GA 
 
Mouse qRT-PCR for Krt5 
mSFN-F 
 
GTG TGT GCG ACA CCG TAC T Mouse qRT-PCR for SFN 
mSFN-R 
 
CTC GGC TAG GTA GCG GTA G 
 
Mouse qRT-PCR for SFN 
mJAG2-F 
 
TCC TCC TGC TGC TTT GTG AT 
 
Mouse qRT-PCR for JAG2 
mJAG2-R 
 
TGT CAG GCA GGT CCC TTG 
 
Mouse qRT-PCR for JAG2 
hGAPDH qRT FW 
 
TCT CTG CTC CTC CTG TTC 
 
Human qRT-PCR for GAPDH 
hGAPDH qRT Rev 
 
GCC CAA TAC GAC CAA ATC C 
 
Human qRT-PCR for GAPDH 
hDNp63-F 
 
GAA AAC AAT GCC CAG ACT CAA 
 
Human qRT-PCR for ΔNp63 
hDNp63-R 
 
TGC GCG TGG TCT GTG TTA 
 
Human qRT-PCR for ΔNp63 
hCSTA-F 
 
AAA CCC GCC ACT CCA GAA ATC 
 
Human qRT-PCR for CSTA 
hCSTA-R 
 
CAC CTG CTC CTA CCT TAA TGT AG 
 
Human qRT-PCR for CSTA 
hDSP-F 
 
GCA GGA TGT ACT ATT CTC GGC 
 
Human qRT-PCR for DSP 
hDSP-R 
 
CCT GGA TGG TGT TCT GGT TCT 
 
Human qRT-PCR for DSP 
hRHOV-F 
 
CCT CAT CGT CAG CTA CAC CTG 
 
Human qRT-PCR for RHOV 
hRHOV-R 
 
GAA CGA AGT CGG TCA AAA TCC 
 
Human qRT-PCR for RHOV 
hKrt13-F 
 
GAC CGC CAC CAT TGA AAA CAA 
 
Human qRT-PCR for Krt13 
hKrt13-R 
 
TCC AGG TCA GTC TTA GAC AGA G 
 
Human qRT-PCR for Krt13 
hKrt5-F 
 
CCA AGG TTG ATG CAC TGA TGG 
 
Human qRT-PCR for Krt5 
hKrt5-R 
 
TGT CAG AGA CAT GCG TCT GC 
 
Human qRT-PCR for Krt5 
hFAM83F-F 
 
CGT CGG CTT CTA CAT GCC C 
 
Human qRT-PCR for 
FAM83F hFAM83F-R 
 
GCT CTA CGT TCT GTC CTG TCA 
 
Human qRT-PCR for 
FAM83F hBCL9L-F 
 
TCT CGC CTA GCA ACT CAA GTC 
 
Human qRT-PCR for BCL9L 
hBCL9L-R 
 
GAG CAC CAT TCG TCC CCA C 
 
Human qRT-PCR for BCL9L 
hETV5-F 
 
TCA GCA AGT CCC TTT TAT GGT C 
 
Human qRT-PCR for ETV5 
hETV5-R 
 
GCT CTT CAG AAT CGT GAG CCA 
 
Human qRT-PCR for ETV5 
hTEAD4-F 
 
GAA CGG GGA CCC TCC AAT G 
 
Human qRT-PCR for TEAD4 
hTEAD4-R 
 
GCG AGC ATA CTC TGT CTC AAC 
 
Human qRT-PCR for TEAD4 
mouse - control gene 
desert primers 
 
active motif #103720 
 
Mouse ChIP primers – gene 
desert 
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mouse + control 
GAPDH primers 
 
active motif #103726 
 
Mouse ChIP primers +control 
GAPDH 
BCL9L-A FWD set 1 
 
TGG AGG GTT CAT GCT CCT 
 
Mouse ChIP primers BCL9L 
BCL9L-A REV set 1 
 
GAT CTC GTT CGC CCT GTT  
 
Mouse ChIP primers BCL9L 
BCL9L-B FWD set 1 
 
GAG AGG TAG GAT GGG AGA GAA A 
 
Mouse ChIP primers BCL9L 
BCL9L-B REV set 1 
 
GCT GTA GCC CGT GAT GTT 
 
Mouse ChIP primers BCL9L 
BCL9L-C FWD set 1 
 
CTG CAG CTG GGC TCT TC 
 
Mouse ChIP primers BCL9L 
BCL9L-C REV set 1 
 
GGA GGC TCC TGC ATT CTT G 
 
Mouse ChIP primers BCL9L 
BCL9L-D FWD set 3 
 
CCA CTA CGC CTG GCT AAT TT 
 
Mouse ChIP primers BCL9L 
BCL9L-D REV set 3 
 
GCA GAT CAC AAG GTC AAG AGT 
 
Mouse ChIP primers BCL9L 
KRT5-A FWD set 2 
 
CCT GCA AGT CTG AGG AAT GT 
 
Mouse ChIP primers KRT5 
KRT5-A REV set 2 
 
TGT TGA TTT CCA GCC CAT AGT 
 
Mouse ChIP primers KRT5 
KRT5-B FWD set 4 
 
CTC GGC TCT CAG CCT CT 
 
Mouse ChIP primers KRT5 
KRT5-B REV set 4 
 
GGC ATG GCG ATG ACC TC 
 
Mouse ChIP primers KRT5 
KRT5-C FWD set 1 
 
GAG GTG CTG GAG AGA ACA G 
 
Mouse ChIP primers KRT5 
KRT5-C REV set 1 
 
CCC AGT TCT GGA AGG GAT AAA 
 
Mouse ChIP primers KRT5 
KRT5-D FWD set 1  
 
GAG GAT GTG CAG AGG GAA TG 
 
Mouse ChIP primers KRT5 
KRT5-D REV set 1 
 
ACA AAG TGA GTA CCA GGG AAA G 
 
Mouse ChIP primers KRT5 
ETV5-A FWD set 3 
 
CGA CCA GAA TTG GGT CTC TT 
 
Mouse ChIP primers ETV5 
ETV5-A REV set 3 
 
CAG CGA GTT TGT GTG GAA TG 
 
Mouse ChIP primers ETV5 
ETV5-B FWD set 4 
 
AGT CAC CAG TAC GTT CCT TTG 
 
Mouse ChIP primers ETV5 
ETV5-B REV set 4 
 
CAG CTA GGC CAA CTG AAA TAG A  
 
Mouse ChIP primers ETV5 
ETV5-C FWD set 1 
 
CTC TCG ACT TTC CAC CTC TTT G 
 
Mouse ChIP primers ETV5 
ETV5-C REV set 1 
 
GAG GGT AGT TAG GGA ACT CTG T 
 
Mouse ChIP primers ETV5 
ETV5-D FWD set 1 
 
TCC CAA AGT GCT GGG ATT AC 
 
Mouse ChIP primers ETV5 
ETV5-D REV set 1 
 
GTA GAG ACA GGG TTT CGC TAT G 
 
Mouse ChIP primers ETV5 
F1 
 
AAA CTC GAG TGT ACA AAA AAG CAG GCT 
TTA AAG 
 
dCas9 vector cloning primers 
R2 
 
AAA GCT AGC TAA TGC CAA CTT TGT ACA 
AGA AAG CTG 
dCas9 vector cloning primers 
F2 ETV5 1 
 
GTA GAT ACA GCA GTA GGA CTT GTT TTA 
GAG CTA GAA ATA GCA A 
 
dCas9 vector cloning primers 
F2 ETV5 2 
 
GTC TGT GTT GTA CTA AAA CTA GTT TTA 
GAG CTA GAA ATA GCA A 
 
dCas9 vector cloning primers 
F2 ETV5 3 
 
GTG TCG TCA AAG TAT AAT CGG TTT TAG 
AGC TAG AAA TAG CAA 
 
dCas9 vector cloning primers 
F2 ETV5 4 
 
GCA GGG ACT TCA AGA GGG CTT GTT TTA 
GAG CTA GAA ATA GCA A 
 
dCas9 vector cloning primers 
R1 ETV5 1 
 
AAG TCC TAC TGC TGT ATC TAC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
R1 ETV5 2 
 
TAG TTT TAG TAC AAC ACA GAC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
R1 ETV5 3 
 
CGA TTA TAC TTT GAC GAC ACG GTG TTT 
CGT CCT TTC C 
 
dCas9 vector cloning primers 
R1 ETV5 4 
 
AAG CCC TCT TGA AGT CCC TGC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
F2 BCL9L 1 
 
GCC TGG AAG TCC CCA CAT CGG TTT TAG 
AGC TAG AAA TAG CAA 
 
dCas9 vector cloning primers 
F2 BCL9L 2 
 
GAG CTC AAA ACC ACC CCA AAG GTT TTA 
GAG CTA GAA ATA GCA A  
 
dCas9 vector cloning primers 
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F2 BCL9L 3 
 
GGC TTT CAC GTC ATC ACA GGG TTT TAG 
AGC TAG AAA TAG CAA 
 
dCas9 vector cloning primers 
F2 BCL9L 4 
 
GGG AAG TGT GGA GAG CTA CTG TTT TAG 
AGC TAG AAA TAG CAA 
 
dCas9 vector cloning primers 
R1 BCL9L 1 
 
CGA TGT GGG GAC TTC CAG GCG GTG TTT 
CGT CCT TTC C 
 
dCas9 vector cloning primers 
R1 BCL9L 2 
 
CTT TGG GGT GGT TTT GAG CTC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
R1 BCL9L 3 
 
CCT GTG ATG ACG TGA AAG CCG GTG TTT 
CGT CCT TTC C 
 
dCas9 vector cloning primers 
R1 BCL9L 4 
 
AGT AGC TCT CCA CAC TTC CCG GTG TTT 
CGT CCT TTC C 
 
dCas9 vector cloning primers 
F2 Krt5v2 1  
 
GCC AGC CAA AGC ATT TAC CCA GTT TTA 
GAG CTA GAA ATA GCA A  
 
dCas9 vector cloning primers 
F2 Krt5v2 2 
 
GAC CCC TTA ATC CAT GGT CAG GTT TTA 
GAG CTA GAA ATA GCA A  
 
dCas9 vector cloning primers 
F2 Krt5v2 3 
 
GAG GTG GAT GAA TCA TAA CAC GTT TTA 
GAG CTA GAA ATA GCA A 
 
dCas9 vector cloning primers 
F2 Krt5v2 4 
 
GCA AAC ATG AAG GAT GCT CAA GTT TTA 
GAG CTA GAA ATA GCA A 
 
dCas9 vector cloning primers 
R1 Krt5v2 1 
 
TGG GTA AAT GCT TTG GCT GGC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
R1 Krt5v2 2 
 
CTG ACC ATG GAT TAA GGG GTC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
R1 Krt5v2 3 
 
GTG TTA TGA TTC ATC CAC CTC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
R1 Krt5v2 4 
 
TTG AGC ATC CTT CAT GTT TGC GGT GTT 
TCG TCC TTT CC 
 
dCas9 vector cloning primers 
AscIDNp63F 
 
GGG CGC GCC ATG TTG TAC CTG GAA AAC 
AAT GCC C 
 
dCas9 vector cloning primers 
PacIDNp63-R 
 
GTT AAT TAA CTA CTC CCC CTC CTC TTT 
GAT GCG CTG T 
 
dCas9 vector cloning primers 
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